Showing 5621-5630 of 8839 results for "".
- FDA Clears Sculptura Radiation Oncology System from Sensus Healthcarehttps://practicaldermatology.com/news/fda-clears-sculptura-radiation-oncology-system-from-sensus-healthcare/2459884/The FDA has granted market clearance for the Sculptura radiation oncology system from Sensus Healthcare, Inc. With a single treatment during surgery, Sculptura can provide cancer patients and physicians a single radiation treatment at the
- Hoth Therapeutics Names Dr. Adam Friedman to Scientific Advisory Boardhttps://practicaldermatology.com/news/hoth-therapeutics-names-dr-adam-friedman-to-scientific-advisory-board/2459887/Hoth Therapeutics, Inc. has named Adam Friedman, MD to the Company's Scientific Advisory Board. Hoth is a development stage biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis. The Scientific Adviso
- Sienna Biopharmaceuticals: Promising Topline Results for SNA-001 for Hair Removalhttps://practicaldermatology.com/news/sienna-biopharmaceuticals-promising-topline-results-for-sna-001-for-hair-removal/2459899/Topline results from the pivotal trial of Sienna Biopharmaceuticals’ SNA-001 show that the topical agent in conjunction with an 810nm diode laser was statistically superior compared to vehicle plus laser. In the study involving 65 male and female patients with white, gray, blonde, light red
- Combination Surgical Excision/Laser Treatment Improves Outcomes, Patient Satisfaction for CMNhttps://practicaldermatology.com/news/combination-surgical-excisionlaser-treatment-improves-outcomes-patient-satisfaction-for-cmn/2459908/Combining lasers with surgical excision produces cosmetically superior results compared to laser-only treatments for small to medium congenital melanocytic nevi (CMN), according to a new review. The
- Study Finds Lack of Disclosure of Potential Conflicts of Interest in Dermatology Patient Advocacy Organizationshttps://practicaldermatology.com/news/study-finds-lack-of-disclosure-of-potential-conflicts-of-interest-in-dermatology-patient-advocacy-organizations/2459912/A recent study published in JAMA Dermatology was conducted to examine potential financial conflicts of interest and characterize disclosure practices among dermatology patient advocacy organizations. For this cross-sectional study of the largest dermatology patient ad
- Remembering a Legend: Vic A Narurkar, MDhttps://practicaldermatology.com/news/remembering-a-legend-vic-a-narurkar-md/2459921/The dermatology community lost a true rock star with the sudden passing of Vic A Narurkar MD, FAAD in late January. Loved by so many, Dr. Narurkar was the Founder of the Bay Area Laser Institute in San Francisco and a past president of the American Society of Cosmetic Derma
- New “Own Your Look” Botox Campaign Targets Millennialshttps://practicaldermatology.com/news/new-own-your-look-botox-campaign-targets-millennials/2459923/Allergan’s new direct-to-consumer campaign, "Own Your Look," aims to address the most common misconceptions around Botox Cosmetic (onabotulinumtoxinA) among millennials, namely the fear of looking frozen. This is the first campaign from the brand created specifically to ad
- Dermatologists Call for Changes to Off-label Coverage Decisionshttps://practicaldermatology.com/news/dermatologists-call-for-changes-to-off-label-coverage-decisions/2459926/Dermatologists report major inconsistencies in Medicare Reimbursement Policy for off-label prescriptions and are now calling for an appeal process for cases where coverage is denied. Researchers from several institutions, including the Perelman School of Medicine at the University of Pennsylvania
- HydraFacial Company Partners With Alastin Skincarehttps://practicaldermatology.com/news/hydrafacial-company-partners-with-alastin-skincare/2459931/Alastin Skincare’s TriHex-Pro Skin Booster Serum is now available at HydraFacial providers across the United States. The key ingredient in the TriHex-Pro Skin Booster Serum is Alastin's proprieta
- New Review Highlights Comprehensive Treatment Guidelines for Severe ADhttps://practicaldermatology.com/news/new-review-highlights-comprehensive-treatment-guidelines-for-severe-ad/2459936/A team of investigators from the University of Colorado College of Nursing at CU Anschutz Medical Campus and National Jewish Health has identified comprehensive guidelines for managing severe atopic dermatitis (AD). The